We have shown that in NKTCL, JAK3 transferred to the nucleus and phosphorylated PRC2 methyltransferase EZH2 at Y244, switching EZH2 from an epigenetic silencer to a transcriptional activator (Figure 2B). Here, JAK3 is linked to extranodal nasal NK/T cell lymphoma.